Pharmacokinetic evaluation of gemcitabine and 2′,2′-difluorodeoxycytidine-5′-triphosphate after prolonged infusion in patients affected by different solid tumors
Luigi Cattel(University of Turin), Fulvia Pedani(Ospedale San Giovanni Antica Sede), Laura Delprino(University of Turin), Mario Airoldi, Paola Milla(University of Turin), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 45
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k